What is Aurora Pharmaceutical?
Aurora Pharmaceutical, LLC, headquartered in Northfield, Minnesota, is dedicated to the development and manufacturing of veterinary pharmaceutical products. The company's core mission is to enhance the health and well-being of both livestock and companion animals through carefully formulated medicines. Recognizing the deep bond between owners and their animals, Aurora Pharmaceutical strives to provide solutions that alleviate suffering and improve the quality of life for pets and farm animals alike.
How much funding has Aurora Pharmaceutical raised?
Aurora Pharmaceutical has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Aurora Pharmaceutical
PPP
Public-Private Partnership
What's next for Aurora Pharmaceutical?
With its substantial late-stage funding, Aurora Pharmaceutical is poised for accelerated growth and market expansion. The recent strategic investment suggests confidence from backers in the company's product pipeline and its ability to scale operations. Future endeavors will likely focus on broadening its product portfolio, increasing manufacturing capacity, and strengthening its market presence in the competitive veterinary pharmaceutical landscape. This capital infusion is expected to fuel further research and development, potentially leading to innovative treatments that address unmet needs in animal healthcare.
See full Aurora Pharmaceutical company page
